Clinical Focus
Business Focus
Spotlight
CE/CME
- CDC
- Heart Failure
- Cardiovascular Clinical Consult
- Adult Immunization
- Hepatic Disease
- Rare Disorders
- Pediatric Immunization
- Implementing The Topcon Ocular Telehealth Platform
- Weight Management
- Monkeypox
- Guidelines
- Men's Health
- Psychiatry
- Allergy
- Nutrition
- Women's Health
- Cardiology
- Substance Use
- Pediatrics
- Kidney Disease
- Genetics
- Complimentary & Alternative Medicine
- Dermatology
- Endocrinology
- Oral Medicine
- Otorhinolaryngologic Diseases
- Pain
- Gastrointestinal Disorders
- Geriatrics
- Infection
- Musculoskeletal Disorders
- Obesity
- Rheumatology
- Technology
- Cancer
- Nephrology
- Anemia
- Neurology
- Pulmonology
COVID-19 Update: US Vaccinations, Booster Doses, & Global Data as of July 29, 2022
Data from the CDC on US vaccination and booster shot rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.
US COVID-19 vaccination & booster dose status
US COVID-19 vaccination status according to the Centers for Disease Control and Prevention (CDC) as of July 27, 2022, at 6:00 AM, EDT:
Fully vaccinated plus 2 booster doses:
• Aged ≥50 years 30.9%
• Aged ≥65 years 37.8%
Fully vaccinated plus 1 booster dose:
• Total US population 48.3%
Fully vaccinated in key age groups:
• Total US population 67.2%
• Aged ≥5 years 71.5%
• Aged ≥65 years 91.9%
US confirmed cases of COVID-19 and deaths
Confirmed US cases of COVID-19 and related deaths according to the Johns Hopkins COVID-19 interactive map, as of July 29, 2022 at 3:46 PM, EDT.
3 states with highest number of new cases in past 28 days
• California 514 093
• Texas 331 053
• Florida 296 228
• Total US confirmed cases 91 201 657
• Total US confirmed deaths 1 029 502
Global total COVID-19 confirmed cases, deaths, vaccine doses administered:
• Cases 575 483 721
• Deaths 6 397 196 • Vaccine doses administered 11 959 376 049
Related Videos
Related Content
Remdesivir Linked to Lower Mortality in Patients with COVID-19 Requiring Supplemental Oxygen
October 31st 2023Article
Remdesivir use was associated with increased survival among patients hospitalized with COVID-19 requiring supplemental oxygen across SARS-CoV-2 variants of concern, report researchers.
